Aurinia Pharmaceuticals Inc. ($AUPH)

Earnings Call Transcript · June 3, 2026

NasdaqGM US Health Care Biotechnology Shareholder/Analyst Calls

Earnings Call Speaker Segments

Kevin Tang

Executives
#1

Hello, and welcome to the 2026 Aurinia Pharmaceuticals Annual General Meeting. The meeting will now come to order. My name is Kevin Tang, and I am Aurinia's Chief Executive Officer. Pursuant to Aurinia's bylaws, I will be acting as Chair of the meeting. I will ask Stephen Robertson, Corporate Secretary, to act as Secretary for this meeting, and I will ask Kyle Gould of Computershare Trust Company of Canada to act as the scrutineer of the meeting. Has the Annual General Meeting been properly called?

Stephen P. Robertson

Executives
#2

The record date for this meeting was the close of business on April 14, 2026. And I have an affidavit of a representative of Computershare Trust Company of Canada, attesting that the materials prepared in connection with the meeting were delivered in accordance with the Business Corporations Act of Alberta and applicable securities laws to all shareholders of record as of the close of business on April 14, 2026. Therefore, this Annual General Meeting has been properly called.

Kevin Tang

Executives
#3

I will not read the notice of meeting unless there are any objections.

Stephen P. Robertson

Executives
#4

There are no objections.

Kevin Tang

Executives
#5

Great. Okay. So according to Aurinia's bylaws, quorum for the meeting is at least 2 shareholders present in person or proxy holding in the aggregate, not less than 33.3333% of the outstanding shares carrying the right to vote at this meeting. The preliminary scrutineer's report indicates that 142 shareholders representing in person or by proxy, 67% of the shares issued and outstanding as of the record date are represented today. I adopt the scrutineer's report on attendance and declare that a quorum is present. I declare that the Annual General Meeting is regularly called and properly constituted for the transaction of business. And therefore, I would like to ask the Secretary to explain the voting procedures to be followed at the meeting.

Stephen P. Robertson

Executives
#6

There is 1 outstanding class of shares in the corporation, common shares, which are entitled to vote. Each shareholder is entitled to 1 vote per common share held. Voting for each resolution will be by an online voting mechanism. Only registered shareholders or validly appointed proxy holders may vote at the meeting. The online voting mechanism will be open for all resolutions at the same time. Voting for each matter will remain open until the chair declares the voting close for that matter. At the appropriate time, you should see a voting icon on your screen and the resolution wording will be displayed. To vote, select one of the voting options. Your response will be highlighted. A confirmation message will appear to show that your vote has been received. In order for your vote to be properly recorded, you must remain connected to the Internet. If you are not connected, your vote will not be recorded. If you previously voted by completing and delivering a proxy and a choice was specified in the proxy, you should not cast another vote unless you wish to revoke your proxy. Only registered shareholders or validly appointed proxy holders will be able to ask questions. If you wish to ask a question, select the messaging icon and taper question within the chat box at the bottom of the messaging screen. Click this end button, and you should receive a confirmation that your message has been received. If you have a question related to the proposals that are being considered at this meeting, please submit them now for consideration at the appropriate time.

Kevin Tang

Executives
#7

Thank you, Stephen. Voting for all proposals is now open. Please cast your vote prior to voting being closed for each matter. Copies of the audited financial statements and auditor's report were made available to shareholders and were filed in Aurinia's annual report to shareholders on EDGAR and SEDAR+. Unless there are questions arising from the audited financial statements and auditor's report, I will consider them received by the shareholders as submitted to the meeting.

Stephen P. Robertson

Executives
#8

There are no questions.

Kevin Tang

Executives
#9

In respect to our first item of business, Aurinia's management information circular and proxy statement that was provided to shareholders contains the names of and information about Aurinia's nominees to the Board of Directors. There are 5 positions to be filled each until the next annual meeting. Can I have a motion please that Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson, and Tina Nova be elected to hold office until the next annual meeting of shareholders.

Stephen P. Robertson

Executives
#10

So moved?

Kyle Gould

Attendees
#11

I second the motion.

Kevin Tang

Executives
#12

Great. Is there any discussion on the motion?

Stephen P. Robertson

Executives
#13

There is no discussion.

Kevin Tang

Executives
#14

Since there is no discussion, please cast your vote for each nominee individually. [Voting]

Kevin Tang

Executives
#15

Voting for this motion is closed. Based on the votes available to me, I declare that Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina Nova are elected to hold office as directors until the next Annual Meeting of Shareholders. In respect of our second item of business, can I have a motion that PricewaterhouseCoopers LLP, chartered professional accountants, be appointed as auditors of the corporation until the close of the next annual meeting of shareholders or until a successor is appointed.

Stephen P. Robertson

Executives
#16

So moved?

Unknown Executive

Executives
#17

I second the motion.

Kevin Tang

Executives
#18

Is there any discussion on the motion?

Stephen P. Robertson

Executives
#19

There is no discussion.

Kevin Tang

Executives
#20

Since there is no discussion, please cast your vote on the motion. [Voting]

Kevin Tang

Executives
#21

Voting on this motion is now closed. Based on the votes available to me, I declare the motion carried. In respect to our third item of business, can I have a motion to approve on a nonbinding basis, a say on pay resolution regarding Aurinia's executive compensation as set out in Aurinia's management information circular and proxy statement for the meeting.

Stephen P. Robertson

Executives
#22

So moved?

Unknown Executive

Executives
#23

I second the motion. .

Kevin Tang

Executives
#24

Is there any discussion on the motion?

Stephen P. Robertson

Executives
#25

There is no discussion.

Kevin Tang

Executives
#26

Since there is no discussion, please cast your vote on a nonbinding advisory basis on the motion. [Voting]

Kevin Tang

Executives
#27

Voting for this motion is now closed. Based on the votes available to me, I declare the motion carried. The scrutineers will tabulate the votes and the results of the meeting will be available on EDGAR and SEDAR+ in due course following today's meeting. This concludes all matters set out in the notice of meeting. Is there any further business?

Stephen P. Robertson

Executives
#28

There is no further business.

Kevin Tang

Executives
#29

Since there is no further business, I declare the Annual General Meeting of the corporation concluded. Thank you all very much.

For developers and AI pipelines

Programmatic access to Aurinia Pharmaceuticals Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.